Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.
Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check4 days agoChange DetectedDifference0.6%
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.4%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check26 days agoChange DetectedDifference0.9%
- Check34 days agoChange DetectedSeveral links related to chronic lymphocytic leukemia, lymphoma, and other rare diseases have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference6%
- Check41 days agoChange DetectedNew resources related to leukemia, lymphoma, and chronic graft-versus-host disease have been added, including links to MedlinePlus and Rare Diseases information.SummaryDifference1%
Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.